Maxigen Biotech (TPE:1783) 5-Year EBITDA Growth Rate : 20.30% (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Maxigen Biotech 5-Year EBITDA Growth Rate?

Maxigen Biotech's EBITDA per Share for the three months ended in Mar. 2024 was NT$0.36.

During the past 12 months, Maxigen Biotech's average EBITDA Per Share Growth Rate was -7.10% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 21.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 20.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Maxigen Biotech was 108.80% per year. The lowest was -18.80% per year. And the median was 21.35% per year.

Competitive Comparison of Maxigen Biotech's 5-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Maxigen Biotech's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maxigen Biotech's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Maxigen Biotech's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Maxigen Biotech's 5-Year EBITDA Growth Rate falls into.

Maxigen Biotech 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Maxigen Biotech (TPE:1783) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Maxigen Biotech 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Maxigen Biotech's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Maxigen Biotech (TPE:1783) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Maxigen Biotech Inc (TPE:1783) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 88, Keji 1st Rd, Guishan District, Taoyuan City, TWN, 333

Website

https://www.mbi.com.tw

Maxigen Biotech Inc specializes in the developing, manufacturing, and marketing of biomedical and cosmeceutical skincare products. It provides medical devices for orthopedic, ophthalmic, dental, and surgical applications. Skincare product categories include mask series, facial cleansing series, and body care series. The biomedical products segment is primarily engaged in the manufacturing and sales of collagen and bone materials, which forms the majority chunk of the revenue of the group. The consumer products segment is engaged in the manufacturing and sales of beauty care products.

Maxigen Biotech (TPE:1783) Headlines

No Headlines